1. Resources and Training
  2. Dermatology
  3. Product resources and training
  4. XOLAIR® (omalizumab) Resources
  5. Self-administration initiation checklist

Prescribing information

 

Self-administration initiation checklist

Please contact a Novartis representative to order this material.

Rate this content: 
No votes yet
XSU20-C024(1) November 2020.
Dermatology
Resource
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]